USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
PROMMUNE LLC
Address:
4625 SO. 154TH CIR
OMAHA, NE
Phone:
N/A
URL:
N/A
EIN:
460489370
DUNS:
N/A
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
STTR Phase I $627,123.00 2

Award List:

A Peptide-Based Vaccine to Nicotine

Award Year / Program / Phase:
2004 / STTR / Phase I
Award Amount:
$99,510.00
Agency:
HHS
Principal Investigator:
Research Institution:
UNIVERSITY OF NEBRASKA LINCOLN
RI Contact:
N/A
Abstract:
DESCRIPTION (provided by applicant): The primary objective of this Phase I STTR project is to develop an effective, peptide-based nicotine vaccine for use in humans capable of inducing a robust, nicotine-specific antibody (Ab) response with little or no inflammatory side effects. This will be… More

Response-Selective C5a Agonist for the Treatment of Asthma

Award Year / Program / Phase:
2011 / STTR / Phase I
Award Amount:
$527,613.00
Agency:
HHS
Principal Investigator:
Jill A. Poole – 402-559-6266
Research Institution:
UNIVERSITY OF NEBRASKA MEDICAL CENTER
RI Contact:
Abstract:
DESCRIPTION (provided by applicant): An unmet need in the treatment of allergic asthma is an effective therapeutic strategy that focuses on an underlying cause of the disease rather than merely treating or managing its symptoms. At least one well- accepted underlying contributor to the… More